| Consolidation 1 | Consolidation 2 |
---|---|---|
 | (% of isolates) | (% of isolates) |
CNST | 20 (37.7%) | 23 (32.4%) |
Vancomycin resistant | 1 / 15 | 0 / 21 |
Cloxacillin resistant | 14 / 17 | 21 / 22 |
Streptococcus species | 9 (17%) | 17 (23.9%) |
Penicillin resistant | 1 / 7 | 0 / 11 |
Vancomycin resistant | 0 / 3 | 0 / 6 |
Gram Negatives | 11 (20.7%) | 20 (28.1%) |
Ciprofloxacin resistant | 2 / 10 | 8 / 15 |
P/T* resistant | 1 / 10 | 0 / 14 |
Ampicillin resistant | 9 / 9 | 13 / 15 |
Tobramycin resistant | 1 / 8 | 3 / 10 |
Klebsiella species | 2 (3.8%) | 5 (7.0%) |
Ciprofloxacin resistant | 0/2 | 0 / 4 |
P/T* resistant | 0/2 | 0 / 4 |
Ampicillin resistant | 2/2 | 4 / 4 |
Tobramycin resistant | 0/2 | 0 / 3 |
Escherichia coli | 1 (1.9%) | 10 (14.1%) |
Ciprofloxacin resistant | 1/1 | 8 / 8 |
P/T* resistant | 0 / 1 | 0 / 8 |
Ampicillin resistant | 1 / 1 | 7 / 8 |
Tobramycin resistant | 1/1 | 3 / 5 |
Pseudomonas species | 4 (7.6%) | - |
Ciprofloxacin resistant | 1 / 4 | - |
P/T* resistant | 1/1 | - |
Ampicillin resistant | 3/3 | - |
Tobramycin resistant | 0 / 4 | - |